Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide, which Novo markets as Ozempic and Wegovy. on.wsj.com/4ukxeML
https://on.wsj.com/4ukxeML
2026-03-10T16:35:31.054Z